{
  "Entities": [
    {
      "Name": "Demographic Information",
      "Definition": "Information including age, height, weight, and marital status.",
      "Sample Data": "Patient is 45 years old, 165 cm tall, weighs 70 kg, and is single."
    },
    {
      "Name": "Clinical Pathology",
      "Definition": "Details regarding the pathological assessment of breast cancer.",
      "Sample Data": "Invasive ductal carcinoma, grade II."
    },
    {
      "Name": "Treatment Information",
      "Definition": "Data pertaining to the treatment protocols administered, including drug names and surgery details.",
      "Sample Data": "Patient underwent mastectomy followed by adjuvant chemotherapy including Taxol and Herceptin."
    },
    {
      "Name": "Genetic Markers",
      "Definition": "Information on genetic markers relevant to breast cancer such as HER2, ER, and PR status.",
      "Sample Data": "HER2 positive, ER and PR negative."
    },
    {
      "Name": "Prognostic Information",
      "Definition": "Details regarding the prognosis and outcome predictions based on clinical data.",
      "Sample Data": "The estimated 5-year survival rate is 85% based on tumor stage and receptor status."
    }
  ],
  "Dataset": {
    "Name": "Breast Cancer Clinical Notes",
    "Details": "Dataset comprises various types of clinical documentation, including encounter notes, operation records, pathology notes, radiology notes, progress notes, and discharge summaries from 100 breast cancer patients."
  },
  "Annotation Guidelines": {
    "Link": "Not provided; presumably, the guidelines are detailed within the internal documentation or supplementary materials of the study."
  }
}
